Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth

Signaling Pathways as Specific Pharmacologic Targets for Neuroendocrine Tumor Therapy: RET, PI3K, MEK, Growth Factors, and Notch

(2012) Yvette Carter et al.   NEUROENDOCRINOLOGY

Novel Agents Targeting the IGF-1R/PI3K Pathway Impair Cell Proliferation and Survival in Subsets of Medulloblastoma and Neuroblastoma

(2012) Anna Wojtalla et al.   PLoS One

Notch pathway activation induces neuroblastoma tumor cell growth arrest

(2011) Peter E. Zage et al.   PEDIATRIC BLOOD & CANCER

GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line

(2010) Amy Dickey et al.   JOURNAL OF NEURO-ONCOLOGY

The emerging mechanisms of isoform-specific PI3K signalling

(2010) Bart Vanhaesebroeck et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Recent Advances in Neuroblastoma

(2010) John M. Maris   NEW ENGLAND JOURNAL OF MEDICINE

Tautomycin suppresses growth and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathway

(2009) Scott N. Pinchot et al.   AMERICAN JOURNAL OF SURGERY

Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3 

(2009) J. T. Adler et al.   MOLECULAR CANCER THERAPEUTICS

Valproic Acid Activates Notch1 Signaling and Induces Apoptosis in Medullary Thyroid Cancer Cells

(2008) David Yu Greenblatt et al.   ANNALS OF SURGERY

Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy

(2008) Jia Luo   CANCER LETTERS

Maintenance of Constitutive I B Kinase Activity by Glycogen Synthase Kinase-3 /  in Pancreatic Cancer

(2008) W. Wilson et al.   CANCER RESEARCH

A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286

(2008) Javier G. Pizarro et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The insulin-like growth factor system and sarcomas

(2008) Bart Rikhof et al.   JOURNAL OF PATHOLOGY

Preclinical efficacy on GSK-3 inhibitors: Towards a future generation of powerful drugs

(2008) Ana Martinez   MEDICINAL RESEARCH REVIEWS